{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:29:48Z","timestamp":1784204988191,"version":"3.55.0"},"reference-count":15,"publisher":"American Academy of Pediatrics (AAP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>To describe testing and treatment practices for Mycoplasma pneumoniae (Mp) among children hospitalized with community-acquired pneumonia (CAP).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study using the Pediatric Health Information Systems database. We included children 3 months to 18 years old hospitalized with CAP between 2012 and 2018 and excluded children who were transferred from another hospital and those with complex chronic conditions. We examined the proportion of patients receiving Mp testing and macrolide therapy at the hospital level and trends in Mp testing and macrolide prescription over time. At the patient level, we examined differences in demographics, illness severity (eg, blood gas, chest tube placement), and outcomes (eg, ICU admission, length of stay, readmission) among patients with and without Mp testing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Among 103\u2009977 children hospitalized with CAP, 17.3% underwent Mp testing and 31.1% received macrolides. We found no correlation between Mp testing and macrolide treatment at the hospital level (R2 = 0.05; P = .11). Patients tested for Mp were more likely to have blood gas analysis (15.8% vs 12.8%; P &amp;lt; .1), chest tube placement (1.4% vs 0.8%; P &amp;lt; .1), and ICU admission (3.1% vs 1.4%; P &amp;lt; .1). Mp testing increased (from 15.8% to 18.6%; P &amp;lt; .001), and macrolide prescription decreased (from 40.9% to 20.6%; P &amp;lt; .001) between 2012 and 2018.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Nearly one-third of hospitalized children with CAP received macrolide antibiotics, although macrolide prescription decreased over time. Clinicians were more likely to perform Mp testing in children with severe illness, and Mp testing and macrolide treatment were not correlated at the hospital level.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2020-005215","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T09:27:12Z","timestamp":1625131632000},"page":"760-763","source":"Crossref","is-referenced-by-count":10,"title":["Mycoplasma Pneumoniae Testing and Treatment Among Children With Community-Acquired Pneumonia"],"prefix":"10.1542","volume":"11","author":[{"given":"Sanyukta","family":"Desai","sequence":"first","affiliation":[{"name":"Divisions of Hospital Medicine"},{"name":"Department of Pediatrics, School of Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hall","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Association, Lenexa, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Lipsett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Harvard University, Boston, Massachusetts"},{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Divisions of Hospital Medicine and"},{"name":"Infectious Diseases, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"},{"name":"Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas V.","family":"Brogan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, University of Washington, Seattle, Washington"},{"name":"Critical Care, Seattle Children\u2019s Hospital, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L","family":"Hersh","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, School of Medicine, The University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Williams","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G.","family":"Grijalva","sequence":"additional","affiliation":[{"name":"Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Gerber","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Blaschke","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, School of Medicine, The University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"Neuman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Harvard University, Boston, Massachusetts"},{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilliam","family":"Ambroggio","sequence":"additional","affiliation":[{"name":"Sections of Emergency Medicine and Hospital Medicine, Children\u2019s Hospital Colorado and Department of Pediatrics, University of Colorado, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"issue":"9","key":"2021121007503448100_b1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"2021121007503448100_b2","first-page":"CD009175","article-title":"Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia","author":"Wang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2021121007503448100_b3","first-page":"CD004875","article-title":"Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children","author":"Gardiner","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2021121007503448100_b4","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2021121007503448100_b5","doi-asserted-by":"crossref","first-page":"e1001444","DOI":"10.1371\/journal.pmed.1001444","article-title":"Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study","volume":"10","author":"Spuesens","year":"2013","journal-title":"PLoS Med"},{"issue":"12","key":"2021121007503448100_b6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/jamapediatrics.2017.3225","article-title":"Effectiveness of \u03b2-lactam monotherapy vs macrolide combination therapy for children hospitalized with pneumonia","volume":"171","author":"Williams","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2021121007503448100_b7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1542\/peds.2013-3729","article-title":"Treatment of mycoplasma pneumonia: a systematic review","volume":"133","author":"Biondi","year":"2014","journal-title":"Pediatrics"},{"issue":"9","key":"2021121007503448100_b8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamapediatrics.2013.186","article-title":"Identifying pediatric community-acquired pneumonia hospitalizations: accuracy of administrative billing codes","volume":"167","author":"Williams","year":"2013","journal-title":"JAMA Pediatr"},{"key":"2021121007503448100_b9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"issue":"3","key":"2021121007503448100_b10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0196-0644(98)70350-6","article-title":"Patients hospitalized after initial outpatient treatment for community-acquired pneumonia","volume":"31","author":"Minogue","year":"1998","journal-title":"Ann Emerg Med"},{"issue":"5","key":"2021121007503448100_b11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.inf.0000160949.99560.8d","article-title":"Role of atypical bacteria and azithromycin therapy for children with recurrent respiratory tract infections","volume":"24","author":"Esposito","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2021121007503448100_b12","first-page":"5","article-title":"Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia","volume":"68","author":"Kutty","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2021121007503448100_b13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/INF.0000000000002171","article-title":"The art and science of diagnosing Mycoplasma pneumoniae infection","volume":"37","author":"Meyer Sauteur","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"2021121007503448100_b14","doi-asserted-by":"crossref","first-page":"e00968-19","DOI":"10.1128\/JCM.00968-19","article-title":"Macrolide-resistant Mycoplasma pneumoniae in the United States as determined from a national surveillance program","volume":"57","author":"Waites","year":"2019","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2021121007503448100_b15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/cid\/ciz1059","article-title":"Improved diagnostics help to identify clinical features and biomarkers that predict Mycoplasma pneumoniae community-acquired pneumonia in children","volume":"71","author":"Meyer Sauteur","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/11\/7\/760\/1153268\/hpeds_2020-005215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/11\/7\/760\/1153268\/hpeds_2020-005215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T19:29:28Z","timestamp":1639164568000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/11\/7\/760\/179853\/Mycoplasma-Pneumoniae-Testing-and-Treatment-Among"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,1]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2020-005215","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}